Expertise at Chang Gung System

Hung-Ming Wang , M.D.
Institution: Linkou Chang Gung Memorial Hospital
Position: Attending Physician / Professor
Department: Department of Internal Medicine / Hematology-Oncology Division
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-3281200 ext 8825 Fax: +886-3-3281200 ext 2362
E-mail: whm526@cgmh.org.tw

Focus of Interest:
  • Oncology
  • Cancer Research

Employment Records:
Academic Appointment:
◎ Associate professor,
1. School of Medicine, Chang Gung University
2. Chang Gung Institute of Technology (2005/05～2007/12)
◎ Associate professor and attending physician, Division of hematology/oncolog, department of internal medicine, Chang Gung Memorial Hospital
◎ Professor and attending physician, Division of hematology/oncolog, department of internal medicine, Chang Gung Memorial Hospital


Education:
1979－1986，Taipei Medical College，Taipei

Honor and Awards:
  • The 7th Taiwan Joint Cancer Conference, 2002 best poster paper award
  • Invited speaker in XXXIII World Congress of the ICS, 2002, Taipei, Taiwan
  • Invited speaker in 2004 Aventis Oncology Forum (AOF)--Post ASCO Taxotere
  • Update Meeting, Taichung, Taiwan (Taxotere in Head and Neck Cancer)
  • The 11th Taiwan Joint Cancer Conference, 2006 best poster paper award
  • Invited speaker: The 6th Asia Pacific Oncology Summit: The current management issues and latest clinical results in Head & Neck Cancer. October 12, 2008, Xian, China
  • 2009, and 2011: Degrees at Chang Gung Memorial Medical Journal excellent review members
  • 2011 ~ 2012 audit expert of Ministry of Health and Welfare commission on Taiwan Oncology Nursing Society for cancer patients clinical care guidelines of "oral mucositis", and "pain".
  • 2013 External Review Committee of Ministry of Health and Welfare commission on Nutrition Department of Fu Jen Catholic University for development of process for nutrition consultation for head and neck cancer patients.
  • 2013 members of the palliative care service support groups of medical counselling and medical resources of Taoyuan County.

Selected Publications :
  1. Liao CT, Wang HM(co 1st), Chang JT, Lin CY, Ng SH, Huang SF, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010;77(2):421-9.
  2. Chan SC, Wang HM(co-1st), Yen TC, Lin CY, Chin SC, Liao CT, et al. (1)(8)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging 2011;38(9):1607-19.
  3. Hsieh CH, Chang JW, Hsieh JJ, Hsu T, Huang SF, Liao CT, Wang HM (corresponding). Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck 2011;33(12):1758-64.
  4. Chan SC, Wang HM(co-1st), Ng SH, Hsu CL, Lin YJ, Lin CY, et al. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients. J Nucl Med 2012;53(11):1730-5.
  5. Hsu CL. Chang KP. Lin CY. Chang HK. Wang CH. Lin TL. Liao CT. Tsang NM. Lee LY. Chan SC. Ng SH. Li HP. Chang YS. Wang HM(corresponding). Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck 2012;34(8):1064-70.
  6. Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH. Lee LY. Wang HM(corresponding). Chang JT.. The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol 2012;7:215.
  7. Wang HM(corresponding). Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer 2013;21(7):1973-81.
  8. Hsieh CH, Hsu CL, Wang CH, Liaw CC, Chen JS, Chang HK, Yang TS, Chang JW, Lin YC, Liau CT, Tsang NM, Chang JT, Ng SH, Wang, HM(corresponding). Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomed J 2013;36(5):229-36.
  9. Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM(corresponding). Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncol 2013;49(6):620-5.
  10. Wang HM, Hsu CL, Heish CH, Fan KH, Lin C.Y, Chang JTC, Huang SF, Chen IH, Liao CT, Ng SK. Concurrent Chemoradiotherapy Using Cisplatin, Tegafur and Leucovorin for Advanced Squamous Cell Carcinoma of the Hypopharynx and Oropharynx. Biomed J 2014 (ahead of print).

Full Publication List

Board Certification/Professional Affiliations:
Board Certification :
  • The Board of the Specialist of Internal Medicine;
  • The Board of Medical Oncology of the Chinese oncology Society;
  • The Board of Taiwan Society of Cancer Palliative Medicine;
  • The Board of Taiwan Association of Hospice Medicine;
Professional Affiliations:
  • The Chinese Oncology Society
  • American Society of Clinical Oncology
  • The Society of Internal Medicine
  • Formosan Medical Association
  • Taiwan Association of Hospice Medicine
  • Taiwan Society of Cancer Palliative Medicine